Dietary indoles influence the AHR-RORγt axis and mucosal immune homeostasis in ART-treated SIV infection
JCI Insight · 2026
DOI: 10.1172/jci.insight.201258 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Siva Thirugnanam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tulane National Biomedical Research Center, Covington, Louisiana, USA. Hauptthemen laut MEDLINE: Simian Acquired Immunodeficiency Syndrome, Receptors, Aryl Hydrocarbon, Nuclear Receptor Subfamily 1, Group F, Member 3, Indoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
HIV infection rapidly impairs the gastrointestinal barrier, contributing to persistent mucosal immune dysfunction, microbial translocation, and systemic inflammation despite antiretroviral therapy (ART). Using SIV-infected rhesus macaques on long-term ART, we investigated mechanisms underlying impairment in gut barrier–protective IL-17/IL-22 responses and the potential modulation of this pathway by dietary indoles. Longitudinal profiling of colonic epithelial and lamina propria cells revealed a selective loss of IL-17/IL-22–producing γδ T cells and type 3 innate lymphoid cells (ILC3s). This loss correlated with reduced expression of the transcription factors AHR and RORγt and was associated with elevated plasma markers of intestinal epithelial barrier disruption (IEBD), including intestinal fatty acid–binding protein (iFABP), zonulin, and LPS-binding protein (LBP). Targeting this transcriptional deficiency, dietary indole supplementation for 1 month restored colonic AHR + IL-22–producing γδ T cells, RORγt + ILC3s, and Vδ1 T cells, and was associated with reduced iFABP and zonulin levels. Immunohistochemical analyses further demonstrated enrichment of AHR/RORγt-coexpressing cells in the colon of indole-supplemented animals during chronic SIV infection on ART. Collectively, these findings indicate that disruption of the AHR-RORγt axis is a key pathogenic mechanism underlying persistent IEBD in chronic SIV/HIV infection. Modulation of AHR and RORγt signaling pathways in the gut may therefore represent a promising therapeutic strategy to reinforce mucosal barrier function and mitigate chronic inflammation in people living with HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tulane National Biomedical Research Center, Covington, Louisiana, USA.
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
- Department of Microbiology, Immunology and Parasitology, Louisiana State University School of Medicine, New Orleans, Louisiana, USA.
- Louisiana Cancer Research Center, New Orleans, Louisiana, USA.
- Tulane Center for Aging, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Thirugnanam, S., Van Zandt, A. R., McNally, A. B., Hart, V. A., Berthelot, I., Midkiff, C. C., Doyle-Meyers, L. A., Welsh, D. A., Blair, R. V., MacLean, A. G., & Rout, N. (2026). Dietary indoles influence the AHR-RORγt axis and mucosal immune homeostasis in ART-treated SIV infection. JCI Insight. https://doi.org/10.1172/jci.insight.201258
Vancouver
Thirugnanam S, Van Zandt AR, McNally AB, Hart VA, Berthelot I, Midkiff CC, et al. Dietary indoles influence the AHR-RORγt axis and mucosal immune homeostasis in ART-treated SIV infection. JCI Insight. 2026. doi:10.1172/jci.insight.201258
BibTeX
@article{Thirugnanam2026,
author = {Thirugnanam, Siva and Van Zandt, Alison R and McNally, Alexandra B and Hart, Victoria A and Berthelot, Isabelle and Midkiff, Cecily C and Doyle-Meyers, Lara A and Welsh, David A and Blair, Robert V and MacLean, Andrew G and Rout, Namita},
title = {Dietary indoles influence the AHR-RORγt axis and mucosal immune homeostasis in ART-treated SIV infection},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.201258}
}
EUVIMED